Feasibility of a pharmacy-led intervention to de-implement non-guideline-concordant proton pump inhibitor use

BACKGROUND: Proton pump inhibitors (PPIs) are among the most prescribed medications and are often used unnecessarily. PPIs are used for the treatment of heartburn and acid-related disorders. Emerging evidence indicates that PPIs are associated with serious adverse events, such as increased risk of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Musuuza, Jackson S., Fong, Emily, Lata, Paul, Willenborg, Katie, Knobloch, Mary Jo, Hoernke, Margaret J., Spiel, Andrew R., Tischendorf, Jessica S., Suda, Katie J., Safdar, Nasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171048/
https://www.ncbi.nlm.nih.gov/pubmed/34074337
http://dx.doi.org/10.1186/s43058-021-00161-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171048/
https://www.ncbi.nlm.nih.gov/pubmed/34074337
http://dx.doi.org/10.1186/s43058-021-00161-6

Ejemplares similares